+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
ID07840326

Randomized, Double-Blind Study of SUN-627 to Assess Safety and Effects on Neuroinflammation in Adults With Non-Active Progressive Multiple Sclerosis

Led by Sundance Biosciences, Inc. · Updated on 2026-10-30

20

Participants Needed

7

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating SUN-627 in adults aged 18 to 70 years who have been diagnosed with non-active Secondary Progressive Multiple Sclerosis SPMS or Primary Progressive Multiple Sclerosis PPMS. This Phase 2a clinical trial aims to study the safety, tolerability, pharmacokinetics, pharmacodynamics, and its effects on neuroinflammation in the central nervous system. The study is designed as a randomized, double-blind, placebo-controlled trial to compare SUN-627 with placebo. Participants will receive SUN-627 or placebo orally once daily at two different dose levels during the treatment period. The study lasts for 16 weeks, with the treatment phase spanning 12 weeks. SUN-627 is administered as an immediate-release tablet, and the placebo matches the oral administration schedule. The trial includes two experimental groups receiving different SUN-627 doses and one placebo group. Throughout the study, participants will be closely monitored for safety by tracking treatment-emergent and serious adverse events. Researchers will also measure SUN-627 concentrations in plasma and changes from baseline in neuroinflammation biomarkers. Participants will undergo assessments during the 12-week treatment and continue under observation until the study concludes at 16 weeks, providing data on the drugs impact and safety profile.

CONDITIONS

Brief Title

A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)

Research Team

C

Chetan Gandhy, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here